Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-15-080166

Chief Executive Officer bought 850 shares at $1.73 ($1,471)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-11-13 Purchase : show line 1 in the form +850 $1.73 $1,471 6,300 D
Open-market purchases · 850 sh · avg $1.73 · $1,471
Loading xslF345X03/doc4.xml…